In addition, the angiotensin-converting enzyme (ACE) inhibitor enalapril, which blocks AngII formation, did not adequately inhibit aneurysm formation, regardless of the same antihypertensive effect as losartan [40]. The gene discussed is ACE; the disease is aneurysm.